Le Lézard
Classified in: Health
Subject: SVY

Bone Broth Protein Supplements Lab Tested by the Consumer Wellness Center; Results Reveal Presence of Insecticides, Pharmaceuticals and Antimicrobial Preservative Chemicals Linked to Breast Cancer



TUCSON, Ariz., Oct. 6, 2017 /PRNewswire/ -- Bone broth protein products, a staple of the popular "Paleo" diet, have been laboratory tested by the non-profit Consumer Wellness Center and its associated laboratory, CWC Labs (CWClabs.com), an ISO-accredited analytical laboratory specializing in forensic food science.

Results of the tests, acquired via LC-MS-TOF analysis, reveal the presence of insecticides, pharmaceutical chemicals, antimicrobial preservative chemicals and steroidal pheromones. At least one of the chemicals detected in the products ? butylparaben ? has been linked to an increased risk of breast cancer in medical studies.

All products tested were non-organic products. Chemical identification was performed using five different analytical vectors, including accurate mass, isotopic ratios and ion fragmentation "fingerprint" analysis. A summary of the press announcement video has been posted at ConsumerWellness.org, along with highlights of the findings from the lab tests.

The findings indicate the presence of quantities of chemicals that might raise questions among health-conscious consumers. Many bone broth products are marketed as "natural" or "all natural," yet these tests prove they may contain synthetic chemicals that might pose increased risks of diseases such as breast cancer.

In a press announcement video, CWC executive director Mike Adams, who directed the scientific research, raises concern over the "lack of transparency and ethics" in the nutritional supplements industry, which he says consists of a number of highly sophisticated supplement marketing companies whose products are never tested for chemical composition.

The Consumer Wellness Center is not claiming the products pose an acute danger, nor that they violate current FDA regulations which allow unlimited quantities of pesticides and other chemicals in the U.S. food supply. Instead, the CWC announcement is aimed at providing consumers with greater transparency about what they are purchasing and consuming, especially when such products are consumed in large aggregate quantities by consumers who purchase them based on persuasive marketing that often makes questionable health claims.

Learn more at ConsumerWellness.org.

CONTACT:  

Lacey M.

inquiry@cwclabs.com

520-232-9300 x 115

SOURCE Consumer Wellness Center


These press releases may also interest you

at 13:30
One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose Prediction and Automated Decision Support. Through these new features, the One Drop | Mobile app will...

at 13:01
New research finds that people with type 1 diabetes (T1D) who used the Diabeloop DBLG1 therapeutic, closed-loop insulin delivery system in a home setting experienced a greater percentage of time in the target blood glucose range and fewer...

at 12:43
When adolescents and adults with type 1 diabetes (T1D) used a new continuous glucose monitoring (CGM) device containing a sensor that can remain implanted in the arm for up to 180 days, the system provided accurate glucose measurement with no major...

at 12:43
A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in adults with type 1 diabetes (T1D) compared to an insulin-only, first-generation artificial pancreas,...

at 12:40
Adults with type 1 diabetes using the Omnipod hybrid closed-loop system (the Horizontm Automated Glucose Control System) were studied in a supervised outpatient hotel setting with unrestricted meals and moderate-intensity exercise and  experienced...

at 10:12
Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE)...




News published on 6 october 2017 at 08:00 and distributed by: